Review article: how the intestinal microbiota may reflect disease activity and influence therapeutic outcome in inflammatory bowel disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Review article: how the intestinal microbiota may reflect disease activity and influence therapeutic outcome in inflammatory bowel disease
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-28
DOI
10.1111/apt.16096
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gut Microbiota and Cancer: From Pathogenesis to Therapy
- (2019) Silvia Vivarelli et al. Cancers
- The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn’s & Colitis Foundation
- (2019) K T Park et al. INFLAMMATORY BOWEL DISEASES
- Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients with Inflammatory Bowel Diseases
- (2019) Konrad Aden et al. GASTROENTEROLOGY
- Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses
- (2019) Sara Vieira-Silva et al. Nature Microbiology
- HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease
- (2019) Aleksejs Sazonovs et al. GASTROENTEROLOGY
- The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
- (2018) Vancheswaran Gopalakrishnan et al. CANCER CELL
- Su1794 - Discrimination of Endoscopic Postoperative Recurrence in Patients with Crohn's Disease using Serological Inflammatory Markers
- (2018) Kathleen Machiels et al. GASTROENTEROLOGY
- Gut Microbiota and Type 1 Diabetes
- (2018) Hui Han et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn’s Disease Patients
- (2018) Matthew K. Doherty et al. mBio
- Insights into the role of gut microbiota in obesity: pathogenesis, mechanisms, and therapeutic perspectives
- (2018) Lijuan Sun et al. Protein & Cell
- Inflammatory bowel disease: towards a personalized medicine
- (2018) Mathurin Flamant et al. Therapeutic Advances in Gastroenterology
- Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction
- (2018) Youlian Zhou et al. mSystems
- Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course
- (2018) Melanie Schirmer et al. Cell Host & Microbe
- Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response
- (2018) Yael Haberman et al. Nature Communications
- Gut microbiome structure and metabolic activity in inflammatory bowel disease
- (2018) Eric A. Franzosa et al. Nature Microbiology
- Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
- (2017) Sudarshan Paramsothy et al. LANCET
- Quantitative microbiome profiling links gut community variation to microbial load
- (2017) Doris Vandeputte et al. NATURE
- Effects of Antidiabetic Drugs on Gut Microbiota Composition
- (2017) et al. Genes
- Intestinal Dysbiosis and Rheumatoid Arthritis: A Link between Gut Microbiota and the Pathogenesis of Rheumatoid Arthritis
- (2017) Gabriel Horta-Baas et al. Journal of Immunology Research
- Mirror, mirror on the wall: which microbiomes will help heal them all?
- (2016) Renuka R. Nayak et al. BMC Medicine
- Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease
- (2016) Kenichiro Takahashi et al. DIGESTION
- Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism
- (2016) I Oancea et al. GUT
- Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD
- (2016) João Sabino et al. GUT
- The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
- (2016) Martin Kummen et al. GUT
- Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
- (2016) Romain Daillère et al. IMMUNITY
- Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition
- (2016) Maria K. Magnusson et al. Journal of Crohns & Colitis
- Population-level analysis of gut microbiome variation
- (2016) Gwen Falony et al. SCIENCE
- Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease
- (2016) Kelly A. Shaw et al. Genome Medicine
- Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses
- (2016) Oriana Rossi et al. Scientific Reports
- The fecal microbiota as a biomarker for disease activity in Crohn’s disease
- (2016) Danyta. I. Tedjo et al. Scientific Reports
- Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation
- (2015) Kaija-Leena Kolho et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Proton pump inhibitors affect the gut microbiome
- (2015) Floris Imhann et al. GUT
- Using Corticosteroids to Reshape the Gut Microbiome
- (2015) Edmond Y. Huang et al. INFLAMMATORY BOWEL DISEASES
- Use of antibiotics in patients with Crohn's disease: A systematic review and meta-analysis
- (2015) Jie Wen Su et al. Journal of Digestive Diseases
- Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
- (2015) Benoit Chassaing et al. NATURE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- From historical perspectives to modern therapy: a review of current and future biological treatments for Crohn’s disease
- (2015) Charles W. Randall et al. Therapeutic Advances in Gastroenterology
- The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
- (2014) Dirk Gevers et al. Cell Host & Microbe
- Predictive modeling of gingivitis severity and susceptibility via oral microbiota
- (2014) Shi Huang et al. ISME Journal
- Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature
- (2014) Yael Haberman et al. JOURNAL OF CLINICAL INVESTIGATION
- Fecal Microbial Composition of Ulcerative Colitis and Crohn’s Disease Patients in Remission and Subsequent Exacerbation
- (2014) Edgar S. Wills et al. PLoS One
- Colonisation byFaecalibacterium prausnitziiand maintenance of clinical remission in patients with ulcerative colitis
- (2013) E. Varela et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A decrease of the butyrate-producing speciesRoseburia hominisandFaecalibacterium prausnitziidefines dysbiosis in patients with ulcerative colitis
- (2013) Kathleen Machiels et al. GUT
- Increased Proportions of Bifidobacterium and the Lactobacillus Group and Loss of Butyrate-Producing Bacteria in Inflammatory Bowel Disease
- (2013) W. Wang et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
- (2013) Koji Atarashi et al. NATURE
- Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India
- (2013) Reena Kumari WORLD JOURNAL OF GASTROENTEROLOGY
- The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease
- (2012) Sumei Sha et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- The gut microbiota in IBD
- (2012) Chaysavanh Manichanh et al. Nature Reviews Gastroenterology & Hepatology
- Non-Invasive Mapping of the Gastrointestinal Microbiota Identifies Children with Inflammatory Bowel Disease
- (2012) Eliseo Papa et al. PLoS One
- Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
- (2012) J. C. Arthur et al. SCIENCE
- Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls
- (2012) L.K. Vigsnæs et al. Beneficial Microbes
- Mesalamine in the treatment and maintenance of remission of ulcerative colitis
- (2012) Maggie Ham et al. Expert Review of Clinical Pharmacology
- Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome
- (2011) C. N. Andrews et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: faecal transplantation therapy for gastrointestinal disease
- (2011) J. Landy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Desulfovibrio Bacterial Species Are Increased in Ulcerative Colitis
- (2011) Fiachra Rowan et al. DISEASES OF THE COLON & RECTUM
- Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives
- (2011) M. Joossens et al. GUT
- Invasive potential of gut mucosa-derived fusobacterium nucleatum positively correlates with IBD status of the host
- (2011) Jaclyn Strauss et al. INFLAMMATORY BOWEL DISEASES
- The role of infection in the aetiology of inflammatory bowel disease
- (2010) Richard Hansen et al. JOURNAL OF GASTROENTEROLOGY
- Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
- (2009) I. Arijs et al. GUT
- Effects of mesalamine (5-aminosalicylic acid) on bacterial gene expression
- (2009) Jaime Kaufman et al. INFLAMMATORY BOWEL DISEASES
- Low counts of Faecalibacterium prausnitzii in colitis microbiota
- (2009) H. Sokol et al. INFLAMMATORY BOWEL DISEASES
- Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohnʼs disease
- (2009) Si Ming Man et al. INFLAMMATORY BOWEL DISEASES
- Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohnʼs disease
- (2008) Ben Willing et al. INFLAMMATORY BOWEL DISEASES
- Molecular analysis of the gut microbiota of identical twins with Crohn's disease
- (2008) Johan Dicksved et al. ISME Journal
- Inter-kingdom signalling: communication between bacteria and their hosts
- (2008) David T. Hughes et al. NATURE REVIEWS MICROBIOLOGY
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
- (2008) H. Sokol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Active Crohnʼs disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora
- (2007) Alexander Swidsinski et al. INFLAMMATORY BOWEL DISEASES
- Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease
- (2007) Hiromasa Takaishi et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now